King Legacy, a wholly owned subsidiary of Pfizer recalls Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-co
Recalled May 29, 2013 · FDA recall D-429-2013 · King Legacy, a wholly owned subsidiary of Pfizer
Hazard
Subpotent Drug: The products were below specification for potency at the expiry stability point. · FDA Class II
Units
56,405 bottles
Sold at
Nationwide and Puerto Rico
Description
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Product
Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles (NDC 60793-858-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
Manufacturer(s)
King Legacy, a wholly owned subsidiary of Pfizer
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →